期刊文献+

高尿酸血症小鼠模型的复制与应用体会 被引量:3

Replication and Application Experience of Hyperuricemia Mouse Model
暂未订购
导出
摘要 目的探讨高尿酸血症小鼠模型复制过程中出现的影响因素并对解决这些影响因素进行分析。方法用次黄嘌呤加氧嗪酸钾复制高尿酸血症模型,在复制过程中,就动物的种类、性别、给药的途径、剂量,血尿酸值、测尿酸选时等进行观察比较。结果经模型复制发现,由于动物的种类、性别、给药的途径、剂量不同等因素,会给模型复制产生不同的影响。结论由于多种因素的影响,次黄嘌呤加氧嗪酸钾复制高尿酸血症模型时应引起注意。 Objective To explore and analyze the factors appeared in process of replicated hyperuricemia mouse model.Methods Hyperuricemia mouse model was replicated with hypoxanthine and oteracil potassium,In replication of the rocess,the animals species、sex、drug delivery means and dosage、blood uric acid value and the test time were observed and compared.Results The replicated model indicated that all the factors including the animal species、sex、drug delivery approach、dosage,etc,could lead to different influences.Conclusion Due to the influence of many factors,hypoxanthine and oteracil potassium hyperuricemia replication model should be given attention.Drug delivery means
出处 《实验动物科学》 2012年第4期37-39,共3页 Laboratory Animal Science
关键词 次黄嘌呤 氧嗪酸钾 高尿酸血症 动物模型 hypoxanthine; oteracil potassium; hyperuricemia; animal model
  • 相关文献

参考文献5

  • 1Choi H K, Curhan G. Gout: epidemiology and lifestyle choices [ J ]. Curr Opin Rheum atol,2005,17 ( 3 ) : 341 345.
  • 2Sanchez-Lozada L G, Nakagawa T, Kang D H, et al. Hormonal andcytokine effects of uric acid [ J ]. Cur Opin Nephrol Hypertens,2006 ,15 :30 33.
  • 3Kang D H ,Nakagawa T,Feng L L,et al. A role for uric acid inthe progression of renal disease [ J ]. J Am Soc Nephrol, 2002,13 (12) :2888 - 2897.
  • 4朱克克,陈光亮,马泽彬.高尿酸血症实验模型概况[J].安徽中医学院学报,2011,30(1):78-80. 被引量:8
  • 5刘晓燕,朱学江,郭军,吴辉文,王迎伟.不同品系小鼠对代谢性高尿酸血症造模的影响[J].现代生物医学进展,2011,11(24):4824-4827. 被引量:12

二级参考文献37

共引文献18

同被引文献32

  • 1郭丽萍,王睿.高尿酸血症的流行病学特点和药物应用[J].中国药物应用与监测,2006,3(4):24-27. 被引量:17
  • 2张健,林玉英,孔令义.蒌蒿的化学成分研究[J].中草药,2004,35(9):979-980. 被引量:16
  • 3颜流水,黄智敏,胡臻恺,万益群,陈燕清.藜蒿中黄酮类化合物的微波辅助萃取研究[J].分析试验室,2006,25(3):66-69. 被引量:25
  • 4LUK A J, SIMKIN P A. Epidemiology of Hyperurice- mia and Gout[J]. American Journal of Managed Care, 2005,11(15 Suppl) :S435-442.
  • 5DEW T P,DAY A J ,MORGAN M R A. Xanthine Ox- idase Activity in Vitro: effects of Food Extracts and Components [J]. Journal of Agricultural and Food Chemistry, 2005,53(16) : 6510-6515.
  • 6LAVELLI V, PERI C, RIZZOLO A. Antioxidant Ac-tivity of Tomato Products as Studied by Model Reac- tions Using Xanthine Oxidase, Myetoperoxidase, and Copper-induced Lipid Peroxidation[J]. Journal of Agri- cultural and Food Chemistry, 2000,48 (5) : 1442-1448.
  • 7SONG Y S,KIM S H,SA J H,et al. Anti-angiogenic, Antioxidant and Xanthine Oxidase Inhibition Activities of the Mushroom Phellinus Linteus[J]. Journal of Eth- nopharmacology, 2003,88(1) : 113-116.
  • 8PATRICK L OWEN, TIMOTHY JOHNS. Xanthine Oxidase Inhibitory Activity of Northeastern North A- merican Plant Remedies Used for Gout [J]. Journal of Ethnopharmacology, 1999,64 : 149-160.
  • 9KONG L D, CAI Y, HUANG W W. Cheng. Inhibition of Xanthine Oxidase by Some Chinese Medicinal Olants Used to Treat Gout[J]. Journal of Ethnopahrmacolo- gy, 2000,73 : 199-207.
  • 10COS P, YING L, CALOMME M, et al. Structure Ac- tivity Relationship and Classification of Flavonoids as Inhibitors of Xanthine Oxidase and Super Oxide Scav- engers[J]. Journal of natural products, 1998,61 ( 1 ) : 71- 76.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部